Ingredients:
Each hard capsule contains:
Isomax- 40% (Isoflavon 40% – Soybean sprout extract) 60mg
Dang Gui extract (Radix Angelicae sinensis) 50mg
White Peony extract (Paeonia lactiflora) 50mg
Hydrolyzed Collagen 40mg
Aquamin F (Seaweed extract containing 32% Calcium) 30mg
Reishi Mushroom extract (Ganoderma lucidum) 30mg
Tienchi Ginseng extract (Panax pseudo-ginseng Wall.) 30mg
Szechuan Lovage Rhizome extract (Conioselinum univitatum Turcz) 25mg
Evening Primrose Oil 20mg
Prepared Rehmannia Root extract (Radix Rehmanniae praeparatus) 20mg
Vitamin E (Dl-alpha-tocopheryl) 24IU
Excipients: PVP K30 (polyvinylpyrrolidone K30), ethanol 96%, talcum powder, magnesium stearate, nipagin, nipasol, capsule shell (gelatin), cassava starch, calcium carbonate.
(*): The extract to herb ratio is equivalent to 1/10
Uses:
Supports reducing symptoms of hot flashes, insomnia, and decreased libido due to reduced female hormones.
Note: This product is not a medicine and does not replace medication.
Do not use if you are sensitive to any of the product’s ingredients.
Dosage:
Take 1 capsule per dose, 2 times a day. Take after meals.
Note: Not for use by pregnant or breastfeeding women, individuals with bloating, diarrhea, or sensitivities to any of the product’s ingredients. Those on medication should consult a doctor before use.
Additional Information
Storage:
Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.
Target Users:
- Adult women experiencing symptoms of hot flashes, insomnia, and decreased libido due to reduced female hormones.
- Women in perimenopause or menopause.
This product is not a medicine and does not replace medication.
Manufacturer and Product Responsibility:
Hatay Pharmaceutical and Medical Equipment Joint Stock Company
Address: No. 10, Alley 4, Xom Street, Phu Lam Ward, Ha Dong District, Hanoi City
Distributor:
Hataphar Healthcare Vietnam High-Tech Pharmaceutical Joint Stock Company
Address: 80 Quang Trung, Ha Dong District, Hanoi City
Hotline: 1900 66 88 34
Registration Number: 2816/2022/ĐKSP
Advertisement Approval Number: 1559/2022/XNQC-ATTP